Metronidazole-Associated Peripheral Neuropathy in a Patient With End-Stage Renal Failure

Metronidazole is a broad-spectrum antimicrobial that is associated with 0.16% 100-day incidence rates for peripheral neuropathy. In this report, we present an interesting and rare presentation of peripheral neuropathy secondary to metronidazole use for Serratia bacteremia and sepsis in a patient with end-stage renal failure.